# R-2487 in Patients With Rheumatoid Arthritis

> **NCT05961592** · PHASE1 · RECRUITING · sponsor: **Rise Therapeutics LLC** · enrollment: 73 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** R-2487 DP

## Key facts

- **NCT ID:** NCT05961592
- **Lead sponsor:** Rise Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-19
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961592, "R-2487 in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05961592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*